HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy.
Palma MB, Tronik-Le Roux D, Amin G, Castaneda S, Mobbs AM, Scarafia MA, La Greca A, Daouya M, Poras I, Inda AM, Moro LN, Carosella ED, Garcia MN, Miriuka SG
Sci Rep. 2021 Nov 12;11(1):22158. doi: 10.1038/s41598-021-01572-0. PubMed Article
Palma MB, Tronik-Le Roux D, Amin G, Castaneda S, Mobbs AM, Scarafia MA, La Greca A, Daouya M, Poras I, Inda AM, Moro LN, Carosella ED, Garcia MN, Miriuka SG
Sci Rep. 2021 Nov 12;11(1):22158. doi: 10.1038/s41598-021-01572-0. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 182551 | pSpCas9-Puro HLAG-2A-sgRNA | Cas9 from S.pyogenes with 2A-Puro, and the 2A-sgRNA to targeting exon 2 of human HLA-G gene |
| 182552 | pSpCas9-Puro HLAG-2B-sgRNA | Cas9 from S.pyogenes with 2A-Puro, and the 2B-sgRNA to targeting exon 2 of human HLA-G gene |